Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07033364

Functional Liver After SBRT

Changes in Functional Liver Tissue After Liver Metastasis Irradiation: Pilot Study of Functional Imaging Before and After Stereotactic Body Radiotherapy

Status
Recruiting
Phase
Study type
Observational
Enrollment
15 (estimated)
Sponsor
The Netherlands Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

In this study, the investigators aim to determine the dose-effect relationship between radiation dose and liver function by performing a hepatobiliary scintigraphy (HEBIS) before and after stereotactic body radiotherapy (SBRT) for patients with liver metastases. HEBIS is a nuclear imaging technique to quantitatively assess liver function. It better predicts the risk of postsurgical liver failure compared to volumetry alone. To prevent liver failure after SBRT, current clinical dose constraints require that ≥ 700 ml of normal liver should receive less than 15 Gy in 3 fractions. The exact local dose-effect relation is however unknown. Doses below 15 Gy are still damaging, while liver tissue receiving doses above 15 Gy will retain some function. By associating the 3D radiation dose distribution with the HEBIS scan, the investigators can evaluate the impact of radiation dose on liver function for different dose levels in liver (sub)volumes. This analysis will refine existing dose-effect relationships, enabling more tailored treatment of liver metastases in the future. Ten to fifteen patients will be included to assess functional liver imaging using HEBIS before their treatment and 3 to 4 months after their treatment.

Conditions

Interventions

TypeNameDescription
OTHERFunctional liver imaging using hepatobiliary scintigraphy (HEBIS)The Hepatobiliary scintigraphy (HEBIS) or HIDA scan is a nuclear imaging technique that uses \[99mTc\]Tc-mebrofenin, a iminodiacetic acid (IDA) agent, which is a lidocaine analogue that is taken up by hepatocytes and is eliminated in the biliary tract (Arntz, 2023). This functional liver scan quantitatively assesses liver function of which the potential will be tested to measure liver function before and after radiotherapy.

Timeline

Start date
2025-07-21
Primary completion
2026-04-30
Completion
2026-07-31
First posted
2025-06-24
Last updated
2025-08-20

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT07033364. Inclusion in this directory is not an endorsement.